These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 5681701)

  • 1. Diagnosis and treatment of the hemophilias.
    Levin J
    Md State Med J; 1968 Sep; 17(9):75-7. PubMed ID: 5681701
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of hemophilias--gene therapy to come?
    Vajó Z; Sréter L
    Acta Physiol Hung; 1996; 84(2):191-8. PubMed ID: 9046365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Seminar: the present status of diagnosis and treatment of hemophilia (author's transl)].
    Fischer M
    Zhonghua Nei Ke Za Zhi; 1980 Sep; 19(5):379-81. PubMed ID: 6785049
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of haemophilia.
    Br Med J; 1967 Apr; 2(5544):65-6. PubMed ID: 6020849
    [No Abstract]   [Full Text] [Related]  

  • 5. [Characteristics of the diagnosis, clinical aspects and treatment of hemophilias with specific, circulating anticoagulants].
    Barkagan ZS; Sukhoveeva EIa; Eremin GF; Tolochko OI; Shevchenko VI
    Probl Gematol Pereliv Krovi; 1972 Apr; 17(4):35-41. PubMed ID: 4680852
    [No Abstract]   [Full Text] [Related]  

  • 6. Progress and problems in hemophilia and von Willebrand's disease.
    Abildgaard CF
    Adv Pediatr; 1984; 31():137-77. PubMed ID: 6440429
    [No Abstract]   [Full Text] [Related]  

  • 7. Variables that might affect the outcome of immune tolerance therapy in haemophiliacs with factor VIII inhibitors.
    Ehrenforth S; Kreuz W; Funk M; Auerswald G; Scharrer I
    Thromb Haemost; 1994 Nov; 72(5):784-5. PubMed ID: 7900088
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemofil and other factor VIII concentrates.
    Med Lett Drugs Ther; 1969 Nov; 11(23):96. PubMed ID: 5375104
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic value of cryoprecipitate in hemophilia A].
    Lopaciuk S; Szczepański M; Klenowska Z; Daszyński J; Pawelski S
    Pol Tyg Lek; 1969 Jun; 24(22):829-32. PubMed ID: 4895749
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of haemophilia with purified factor 8 (FI-O-Ta).
    de Tezanos Pinto M
    Hemostase; 1966; 6(1):65-71. PubMed ID: 5911788
    [No Abstract]   [Full Text] [Related]  

  • 11. Can a national all voluntary blood transfusion service by adequate blood component therapy cover actual and future needs of AHF?
    Vox Sang; 1976 Oct; 31(4):296-320. PubMed ID: 960680
    [No Abstract]   [Full Text] [Related]  

  • 12. Prophylactic therapy in classical hemophilia: a preliminary report.
    Robinson PM; Tittley P; Smiley RK
    Can Med Assoc J; 1967 Sep; 97(11):559-61. PubMed ID: 6050888
    [No Abstract]   [Full Text] [Related]  

  • 13. Estimation of the probability of post transfusion hepatitis in hemophilia treatment.
    Davis CE; Grizzle JE; Bryan JA
    Biometrics; 1973 Jun; 29(2):386-92. PubMed ID: 4709517
    [No Abstract]   [Full Text] [Related]  

  • 14. [Substitution therapy of hemophilia A].
    Vlcková M
    Vnitr Lek; 1979 Mar; 25(3):295-300. PubMed ID: 433175
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current status of the preparation and use of antihemophilic fractions in France. (Their use in surgery in hemophilia)].
    Ménaché D; Josso F; Steinbuch M; Soulier JP
    Transfusion (Paris); 1966; 9(3):237-44. PubMed ID: 5969559
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antihemophilic activity of donor blood].
    Shuruev AS
    Probl Gematol Pereliv Krovi; 1976; 21(9):45-6. PubMed ID: 1005391
    [No Abstract]   [Full Text] [Related]  

  • 17. [Substitution therapy with factor 8 and factor IX preparations].
    Landbeck G
    Hamatol Bluttransfus; 1968; 5():29-42. PubMed ID: 5729465
    [No Abstract]   [Full Text] [Related]  

  • 18. Surgical management of the patient with classical hemophilia.
    Croom RD; Hutchin P
    Surg Gynecol Obstet; 1969 Apr; 128(4):793-800. PubMed ID: 4887342
    [No Abstract]   [Full Text] [Related]  

  • 19. Blood products used in the treatment of hemophilia.
    Krasnoff AR; Mangione RA
    Hosp Pharm; 1982 Nov; 17(11):598-9, 602-4. PubMed ID: 10318549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy-induced hepatitis risk in hemophilia patients].
    Schiller WG; Renger FG
    Z Arztl Fortbild (Jena); 1983; 77(19):807-10. PubMed ID: 6417919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.